Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-715-9 | CAS number: 12607-70-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Value used for CSA:
NOAEL (oral, systemic, animal):790 mg/kg bw (383 mg Ni/kg/day) (EPSL, 2009a)
LOAEL (oral, systemic, human):0.012 mg Ni/kg bw/day (Nielsen et al, 1999)
NOAEC (inhalation, systemic, animal): 0.053 mg/L (26 mg Ni/m3; males, MMAD=1.9 µm) (EPSL, 2010)
LOAEC (inhalation, local, animal; read-across): 0.47 mg Ni/m3 (DNEL calculation is based on 12-day repeated dose study-Benson et al, 1987; no appropriate acute data is available)
An acute local inhalation DNEL is derived based on the lung effects (e.g. lung inflammation) associated with nickel subsulphide inhalation. The shortest-term study available examining those effects in animals is a 12-day repeated exposure study. An adjustment factor was derived to extrapolate the results from the repeated exposure study to an equivalent effect concentration in a 4 hr acute exposure. See Appendix C3 for more information.
(Oral, local values are not applicable; Dermal, local or systemic, values are not applicable)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 0.24 mg/L air
Additional information
While there were only two studies that characterized the acute toxicity of nickel hydroxycarbonate, both studies available were conducted according to OECD guidelines using GLP standards. Thus these data sufficiently characterized lethality following oral or inhalation exposure in rats.
Eurofins Product Safety Laboratories (EPSL, 2009a) reported the results of an acute oral toxicity test (Up and Down Procedure) in female rats that yielded an LD50 value of 2,000 mg/kg Ni hydroxycarbonate (95% confidence interval could not be calculated) and a NOAEL of 790 mg nickel hydroxycarbonate/kg body weight.
Eurofins Product Safety Laboratories also conducted an acute, nose-only inhalation study (EPSL, 2010) that incorporated a series of four nickel hydroxycarbonate air concentrations that ranged from 0.053 to 2.09 mg/L over a four hour exposure period. Only one of the female rats died during the study (2.09 mg/L dose group), and thus the female LC50 was considered to be >2.09 mg/L. The male rats were more sensitive to the lethal effects of nickel hydroxycarbonate, resulting in an LC50 of 0.24 mg/L (with a 95% confidence limit of 0.0012-49.7 mg/L).
A more recent inhalation study was conducted due to some concerns regarding the EPSL 2010 study, including the possibility of a gender-specific effect, females tested at only one dose, and male data did not fit a strong dose-response curve. Product Safety Labs (PSL) conducted a nose-only inhalation study in 2021 examining the effects of both male and female rats at four nickel hydroxycarbonate air concentrations ranging from 0.05 to 5 mg/L over a four hour exposure period. Unlike the EPSL 2010 study, the female rats were more sensitive in this study with an LC50 of 0.263 mg/L compared to males with 5.213 mg/L, with a combined LC50 of 0.827 mg/L. The most conservative LC50 in both acute inhalation studies is 0.24 mg/L for male rats (EPSL, 2010) and 0.263 mg/L for female rats (PSL, 2021) should be carried forward as a conservative approach to classification.
No data were available characterizing endpoints other than lethality.
There are no available data on which to evaluate acute dermal toxicity. However, acute toxicity is expected to be low in view of the poor absorption by this route. As oral and inhalation routes of exposure are more relevant and data for these have been provided. Testing for acute dermal toxicity is therefore waived based on this information.
Given the available data, the oral LD50 for rats appears to be somewhere in between 1 and 2 g/kg for different hydroxycarbonate samples, while the inhalation LC50 is conservatively indicated to be 0.24-0.26 mg/L).
The following information is taken into account for any hazard / risk assessment:
ORAL: A recently completed GLP, guideline-based in vivo acute oral toxicity study reported an LD50 of 2,000 mg/kg for Ni hydroxycarbonate and a NOAEL of 790 mg nickel hydroxycarbonate/kg body weight (EPSL, 2009).
INHALATION: Two GLP, guideline-based in vivo acute inhalation toxicity studies reported LC50 values of >2.09 mg/L in females with 0.24 mg/L in males and 0.263 mg/L in females with 5.213 mg/L in males, respectively. However, the lowest LC50 of 0.24 mg/L (concluded for males in the EPSL 2010 study) is carried forward as a conservative approach.
DERMAL: No risk characterisation will be conducted for acute dermal toxicity. Acute systemic effects are not relevant due to the very low dermal absorption of nickel. Acute local effects are covered by the long term DNEL based on prevention of dermal sensitization.
Justification for classification or non-classification
Nickel hydroxycarbonate is currently classified for acute oral toxicity as Acute Tox. 4; H302 according to the 1st ATP to the CLP Regulation.
Nickel hydroxycarbonate is currently classified for acute inhalation toxicity as Acute Tox. 4; H332 according to the 1st ATP to the CLP Regulation. However, Section 1.2.1 of the CLP Regulations states that a minimum classification "shall be applied if none of the following conditions are fulfilled:...the manufacturer or importer has access to data or other information as specified in Part 1 of Annex I that lead to classification in a more severe category compared to the minimum classification. Classification in the more severe category must then be applied". Two GLP, guideline-based in vivo acute inhalation toxicity studies reported LC50 values of >2.09 mg/L in females with 0.24 mg/L in males and 0.263 mg/L in females with 5.213 mg/L in males, respectively. However, the lowest LC50 of 0.24 mg/L (concluded for males in the EPSL 2010 study) is carried forward as a conservative approach. This indicates that a more stringent classification of Acute Tox. 2:H330 is warranted. In accordance with the rules set by the CLP Regulation, the current harmonized classification for acute inhalation toxicity has been changed from Acute Tox. 4;H332 to the more severe classification of Acute Tox. 2:H330 within this registration file. A complete summary of the testing program including results and discussion are provided in the CSR.
Ni hydroxycarbonate is not classified for acute dermal toxicity according to the 1st ATP to the CLP Regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.